Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 11, 2004, Pages 1368-1372

  Jutte, Paul C ^a   Rutgers, S R ^a   Van Altena, R ^a   Uges, D R ^a   Van Horn, J R ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Abscess; Drugs; Effusion; Penetration; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG PENETRATION; FEMALE; HUMAN; LUNG PARENCHYMA; MALE; MINIMUM INHIBITORY CONCENTRATION; PLEURA EFFUSION; PRIORITY JOURNAL; PSOAS ABSCESS; REFERENCE VALUE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NETHERLANDS; PLEURAL EFFUSION; PSOAS ABSCESS; PYRAZINAMIDE; RIFAMPIN; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 10044222173     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998; 53: 536-548.
2. Dutt A K, Moers D, Stead W W. Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin. Am Rev Respir Dis 1992; 145: 1429-1432.
3. Watts H G, Lifeso R M. Tuberculosis of bones and joints. J Bone Joint Surg Am 1996; 78: 288-298.
4. Kumar K. The penetration of drugs into the lesions of spinal tuberculosis. Int Orthop 1992; 16: 67-68.
5. Tuli S M, Kumar K, Sen P C. Penetration of antitubercular drugs in clinical osteoarticular tubercular lesions. Acta Orthop Scand 1977; 48: 362-368.
6. Dymond L C, Russell D W. Rapid determination of isonicotinic acid hydrazide in whole blood with 2,4,6-trinitrobenzene-sulphonic acid. Clinica Chimica Acta 1970; 27: 513-520.
7. Heifets L B. Antituberculous drugs: antimicrobial activity in vitro. In: Heifets L B, ed. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, FL, CRC Press, 1991: 13-57.
8. Carlone N A, Acocella G, Cuffini A M, Forno-Pizzoglio M. Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination. Am Rev Respir Dis 1985; 132: 1274-1277.
9. Dhillon J, Mitchison D A. Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254. Antimicrob Agents Chemother 1989; 33: 1255-1259.
10. Honeybourne D. Antibiotic penetration in the respiratory tract and implications for the selection of antimicrobial therapy. Curr Opin Pulm Med 1997; 3: 170-174.
11. Burman W J. The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review. Am J Med Sci 1997; 313: 355-363.
12. Boman G, Malmborg A S. Rifampicin in plasma and pleural fluid after single oral doses. Eur J Clin Pharmacol 1974; 7: 51-58.
13. Thys J P, Vanderhoeft P, Herchuelz A, Bergmann P, Yourassowsky E. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest 1988; 93: 530-532.
14. Elliott A M, Berning S E, Iseman M D, Peloquin C A. Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tubercle Lung Dis 1995; 76: 463-467.
15. Iseman M D, Madsen L A. Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance. Chest 1991; 100: 124-127.
16. Sahn S A, Iseman M D. Tuberculous empyema. Semin Respir Infect 1999; 14: 82-87.
17. Wu Q Q, Na X K, Tian W C. The concentrations of 4 anti-tuberculous drugs in cold abscesses in patients with bone and joint tuberculosis. Chin Med J (Engl) 1987; 100: 819-822.
18. Ellard G A, Humphries M J, Allen B W. Cerebcospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993; 148: 650-655.
19. Meylan P R, Richman D D, Kornbluth R S. Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure. Am Rev Respir Dis 1992; 145(4 Pt 1): 947-953.
20. Yew W W, Lee J, Chan C Y, Cheung S W, Wong P C, Kwan S Y. Ofloxacin penetration into tuberculous pleural effusion. Antimicrob Agents Chemother 1991; 35: 2159-2160.
21. Dine H, Ahmetoglu A, Baykal S, Sari A, Sayil O, Gumele H R. Image-guided percutaneous drainage of tuberculous iliopsoas and spondylodiskitic abscesses: midterm results. Radiology 2002; 225: 353-358.